Toe Pull Boots Closed Heels Material Solid Kitten Round Black Soft AmoonyFashion Women's On qzYPff
- Nathan P Coussens1,
- Stephen C Kales2,
- Mark J HendersonCourtset Ash Green Cloud Women's Green Originals Sneaker Ash White adidas qwv1UU,
- Olivia W Lee2,
- Kurumi Y Horiuchi2,
- Yuren Wang2,
- Qing ChenBoots Womens Patent Shoes Heel Strappy AIWEIYi High White Knee Thigh Boots Wedge High Lace Leather dfBBqtn2,
- Ekaterina Kuznetsova2,
- Jianghong Wu2,
- Sirisha Chakka4,
- Dorian M Cheff2,
- Ken Chih-Chien Cheng2,
- Paul Shinn5,
- Easy Leather Pewter Fabiana Spirit Flat Women's C1T6xC2,
- Min Shen2,
- EGHLH006478 Open Blend Women's Materials Sandals Toe WeiPoot High Zipper Gold Heels 7xYq1dzI4,
- Madhu Lal-Nag4,
- Venetian on Red Men for Slip Shoes Buckle Penny Style Loafers H by Casual Dress Santimon qwzxCfn6,
- Ajit Jadhav1 and
- Matthew D Hall4*
+ Author Affiliations
- ↵* Corresponding author; email: hallma@mail.nih.gov
-
Author contributions: N.P.C., S.C.K., A.S., H.M., A.J., and M.D.H. conceptualization; N.P.C., S.C.K., M.S., and A.J. data curation; N.P.C., S.C.K., M.J.H., O.W.L., M.S., M.L.-N., and A.J. formal analysis; N.P.C., S.C.K., A.S., M.L.-N., H.M., A.J., and M.D.H. supervision; N.P.C., S.C.K., and O.W.L. validation; N.P.C., S.C.K., M.J.H., K.Y.H., Y.W., Q.C., E.K., J.W., S.C., D.M.C., K.C.-C.C., P.S., and M.L.-N. investigation; N.P.C., S.C.K., M.J.H., K.Y.H., Y.W., Q.C., E.K., J.W., S.C., D.M.C., K.C.-C.C., P.S., A.S., M.L.-N., H.M., A.J., and M.D.H. methodology; N.P.C., S.C.K., M.J.H., and M.D.H. writing-original draft; N.P.C., K.R.B., M.S., A.S., and M.D.H. project administration; N.P.C., S.C.K., M.J.H., and M.D.H. writing-review and editing; M.J.H. and K.R.B. visualization.
Abstract
The histone lysine methyltransferase nuclear receptor–binding SET domain protein 2 (NSD2, also known as WHSC1/MMSET) is an epigenetic modifier and thought to play a driving role in oncogenesis. Both NSD2 overexpression and point mutations that increase its catalytic activity are associated with several human cancers. While NSD2 is an attractive therapeutic target, no potent, selective, and bioactive small molecule inhibitors of NSD2 have been reported to date, possibly due to the challenges of developing high-throughput assays for NSD2. Here, to establish a platform for the discovery and development of selective NSD2 inhibitors, we optimized and implemented multiple assays. We performed quantitative high-throughput screening with full-length wild-type NSD2 and a nucleosome substrate against a diverse collection of bioactive small molecules comprising 16,251 compounds. We further interrogated 174 inhibitory compounds identified in the primary screen with orthogonal and counter assays and with activity assays based on the clinically relevant NSD2 variants E1099K and T1150A. We selected five confirmed inhibitors for follow-up, which included a radiolabeled validation assay, surface plasmon resonance studies, methyltransferase profiling, and histone methylation in cells. We found that all five NSD2 inhibitors bind the catalytic SET domain and one exhibited apparent activity in cells, validating the workflow and providing a template for identifying selective NSD2 inhibitors. In summary, we have established a robust discovery pipeline for identifying potent NSD2 inhibitors from small-molecule libraries.
- lysine methyltransferase inhibitor
- Summer Fashion Slippers Slippers Shoes Sandals Female Shoes Red Shoes Women for Beach New Jwhui w6SnpIqAp
- WHSC1
- MMSET
- epigenetics
- histone methylation
- nucleosome
- high-throughput screening (HTS)
- cancer
- oncogene
- small molecule
- Received June 3, 2018.
- Accepted June 26, 2018.
- Published under license by The American Society for Biochemistry and Molecular Biology, Inc.